Drug profile · INN
mycophenolate
APO-MYCOPHENOLATE
mycophenolate (APO-MYCOPHENOLATE) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 72
News articles 0
Drug details — mycophenolate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 72
- Data quality
- 0.81
Quick answer
mycophenolate (APO-MYCOPHENOLATE) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN mycophenolate
Brand APO-MYCOPHENOLATE
Mechanism Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
Target Inosine-5'-monophosphate dehydrogenase (IMPDH)
Originator Alphapharm Pty Ltd
Mechanism of action
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
Primary target: Inosine-5'-monophosphate dehydrogenase (IMPDH)
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mycophenolate?
mycophenolate (APO-MYCOPHENOLATE) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for mycophenolate?
APO-MYCOPHENOLATE is a marketed brand name for mycophenolate. Check FDA Drugs@FDA for the current US label holder and prescribing information.